CHAMPIONS ONCOLOGY, INC. cotiza a 4.87 USD y tiene una capitalización bursátil de $68M. En los últimos 12 meses ha facturado $61M con un margen de flujo de caja libre del -8.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offer…
| Periodo | 2026-12 | 2025-12 | 2025-09 | 2025-07 |
|---|---|---|---|---|
| Real | — | $0.06 | $0.02 | $-0.12 |
| Estimado | $0.02 | — | $-0.01 | $-0.20 |
| Sorpresa | — | — | +300.0% | +40.0% |
| Métrica | CSBR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 48.0% | 57.0% | -9.0% |
| Operating Margin | -1.9% | -38.6% | +36.7% |
| Net Margin | -2.0% | -33.6% | +31.6% |
| FCF Margin | -8.5% | -13.9% | +5.4% |
| ROE | -29.8% | -40.4% | +10.6% |
| ROA | -4.3% | -32.0% | +27.7% |
| Current Ratio | 0.96 | 2.84 | -1.88 |
| Debt / Equity | — | 0.28 | — |